EnVVeno Medical Corporation
NVNO
Classement en actions
#40245
enVVeno Medical Corporation, based in Irvine, California, is a medical device... enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized replacement venous valve developed for the management of chronic venous insufficiency. This device requires an open surgical procedure for implantation, which involves making a 5-to-6-inch incision in the patient's upper thigh to facilitate placement into the femoral vein. In addition to the VenoValve, enVVeno Medical is actively developing the enVVe system. This innovative system represents a non-surgical, transcatheter approach to venous valve replacement, comprising the enVVe valve itself, a dedicated delivery mechanism, and various supplementary accessories. The company previously operated under the name Hancock Jaffe Laboratories, Inc., before officially rebranding to enVVeno Medical Corporation in October 2021.
Prix de l'action
$10.71
Dernière synchronisation: 2026-07-31
Capitalisation boursière
$176.75K
Changement (1 jour)
0.79%
Changement (1 an)
169,900.00%
Pays
US
Échange EnVVeno Medical Corporation (NVNO)
Catégorie
Healthcare
Capitalisation boursière de EnVVeno Medical Corporation(NVNO)
Capitalisation boursière: $176.75K
En October 2026, EnVVeno Medical Corporation a une capitalisation boursière de $176.75K. Cela fait de EnVVeno Medical Corporation la 40245th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de EnVVeno Medical Corporation du 2018 au 2026
NVNO par rapport au top 5 des plus populaires stocks
| Prix pour NVNO | L’actif B | La capitalisation boursière de B | Résultats | |
|---|---|---|---|---|
$393,979,413
$82.63
|
$5.167T | +6,253,641,474,281.09% | ||
|
$382,369,742
$82.63
|
$5.015T | +6,069,360,977,213.03% | ||
|
$313,259,796
$82.63
|
$4.108T | +4,972,377,717,332.48% | ||
|
$297,514,583
$82.63
|
$3.902T | +4,722,453,701,283.97% | ||
|
$205,067,178
$82.63
|
$2.689T | +3,255,034,574,390.62% |
